MedPath

Preventing Seroma Formation After Axillary Lymph Node Dissection for Breast Cancer by Early Vacuum Assisted Closure

Not Applicable
Conditions
Breast Neoplasms
Registration Number
NCT01731769
Lead Sponsor
Changhai Hospital
Brief Summary

Axillary dissection is the standard treatment for breast cancer patients with positive nodes. However, seroma formation after axillary dissection remains the most common early complication to breast cancer surgery. It can delay the initiation of adjuvant therapy, predispose to wound infection, delay wound healing and has also been linked to arm lymphoedema. Based on some studies and our experience that vacuum assisted closure (VAC)is effective in complex wound failures following axillary dissection and groin dissection, we use VAC to prevent seroma formation after extensive axillary dissection. This study is aimed to evaluate the efficacy, safety and economics benefits of early VAC application on postoperative complications and wound healing after extensive axillary dissection in comparison to conventional suction drain.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
50
Inclusion Criteria
  • Written informed consent
  • patients diagnosed with breast cancer, receiving modified radical mastectomy and axillary dissection;
  • Body Mass Index ≥28;
  • drainage volume within the first 48 hours is more than 200 mL.
Exclusion Criteria
  • Subjects with coagulation disorders shown by exceeding the normal range of any of following: prothrombin time (PT), Quick, activated partial thromboplastin time (aPTT), fibrinogen level, or thrombocytes.
  • Subjects having previously had axillary surgery,
  • Subjects having undergone irradiation therapy to the axillary tissue
  • Subjects having ever received chemotherapy before the surgery,
  • Subjects with known hypersensitivity to components of the surgical sticky membrane

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
seroma formation complication incidencewithin the first 30 days (plus or minus 3 days) after surgery
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Changhai Hospital

🇨🇳

Shanghai, Shanghai, China

Changhai Hospital
🇨🇳Shanghai, Shanghai, China
Hongda Bi, Ph.D
Contact
bihongda0411@yahoo.com.cn

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.